Entera Bio: 2025 Annual Financial Summary
Company Overview Entera Bio is a clinical-stage leader developing oral peptide therapies, specifically focusing on its N-TabĀ® platform. Its lead...
5 articles, transcripts, and reports
Company Overview Entera Bio is a clinical-stage leader developing oral peptide therapies, specifically focusing on its N-TabĀ® platform. Its lead...
Entera Bio Ltd (NASDAQ: ENTX) Q1 2022 Earnings Conference
Entera Bio Ltd (NASDAQ: ENTX) Q2 2021 Earnings Conference
Entera Bio Ltd. (NASDAQ: ENTX) Q4 2020 earnings call dated Mar. 18, 2021 Corporate Participants: Jonathan Lieber — Chief Financial Officer, U.S. Spiros Jamas —…
Entera Bio Ltd (NASDAQ: ENTX) Q4 2020 Earnings Conference